Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,865 | -62 |
| Other Working Capital | 198 | -32 |
| Other Operating Activity | 678 | 65 |
| Operating Cash Flow | $-989 | $-29 |
| Cash Flows From Investing Activities | ||
| Other Investing Activity | -301 | 0 |
| Investing Cash Flow | $-301 | $0 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 2,097 | 609 |
| Financing Cash Flow | $2,097 | $609 |
| Beginning Cash Position | 607 | 26 |
| End Cash Position | 1,414 | 607 |
| Net Cash Flow | $807 | $581 |
| Free Cash Flow | ||
| Operating Cash Flow | -989 | -29 |
| Free Cash Flow | -989 | -29 |